PERCEPTIVE ADVISORS LLC's Net Worth
$1.2 Million
Who is PERCEPTIVE ADVISORS LLC?
PERCEPTIVE ADVISORS LLC has an estimated net worth of $1.2 Million. This is based on reported shares across multiple companies, which include CARGO Therapeutics, Inc., VBI VACCINES INC., ZOGENIX, INC., Prometheus Biosciences, Inc., BIOSANTE PHARMACEUTICALS INC, Crinetics Pharmaceuticals, Inc., ALBIREO PHARMA, INC., Nautilus Biotechnology, Inc., Aldeyra Therapeutics, Inc., ANTARES PHARMA INC, Athira Pharma, Inc., Verrica Pharmaceuticals Inc., LianBio, MeiraGTx Holdings plc, AP PHARMA INC /DE/, ADMA BIOLOGICS, INC., AMICUS THERAPEUTICS INC, Global Blood Therapeutics, Inc., Cerevel Therapeutics Holdings, Inc., Kadmon Holdings, Inc., Menlo Therapeutics Inc., AGILE THERAPEUTICS INC, Solid Biosciences Inc., IsoPlexis Corp, XTL BIOPHARMACEUTICALS LTD, Lyra Therapeutics, Inc., Landos Biopharma, Inc., Motus GI Holdings, Inc., VBI Vaccines Inc/BC, Corium International, Inc., Astria Therapeutics, Inc., SCYNEXIS INC, LEAP THERAPEUTICS, INC., Rain Therapeutics Inc., Quotient Ltd, Athenex, Inc., LA JOLLA PHARMACEUTICAL CO, Versartis, Inc., ACELRX PHARMACEUTICALS INC, Dova Pharmaceuticals, Inc., CHEMBIO DIAGNOSTICS, INC., SOLENO THERAPEUTICS INC, REPROS THERAPEUTICS INC., TRIMERIS INC, Acrivon Therapeutics, Inc., OPTIMER PHARMACEUTICALS INC, Aegerion Pharmaceuticals, Inc., Foamix Pharmaceuticals Ltd., MIRAVANT MEDICAL TECHNOLOGIES, INDEVUS PHARMACEUTICALS INC, BIOENVISION INC, MACROCHEM CORP, PENWEST PHARMACEUTICALS CO, CYPRESS BIOSCIENCE INC, VAPOTHERM INC, Orchestra BioMed Holdings, Inc., and Aja Holdco, Inc..
SEC CIK
PERCEPTIVE ADVISORS LLC's CIK is 0001224962
Past Insider Trading and Trends
2008 was PERCEPTIVE ADVISORS LLC's most active year for acquiring shares with 1 total transactions. PERCEPTIVE ADVISORS LLC's most active month to acquire stocks was the month of February. 2021 saw PERCEPTIVE ADVISORS LLC paying a total of $70,983.15 for 7,063 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CARGO Therapeutics, Inc. (CRGX) Snapshot price: $18.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.25M |
$15.00 | $4,999,995.00 | 3.25M |
Nov 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VBI VACCINES INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +118.25% | 3.38M |
$3.05 | $10,321,062.75 | 6.25M |
Dec 6
| |||
Form 4
| +119.60% | 3.38M |
$3.05 | $10,321,062.75 | 6.21M |
Dec 6
| |||
Form 4
| +24.90% | 650K |
$2.08 | $1,352,000.00 | 3.26M |
Aug 14
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ZOGENIX, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.52% | 100K |
$52.00 | $5,200,000.00 | 4.07M |
Aug 10
| |||
Form 4
| +8.17% | 300K |
$37.50 | $11,250,000.00 | 3.97M |
Oct 3
| |||
Form 4
| +6.44% | 222.06K |
$32.83 | $7,290,059.36 | 3.67M |
Sep 29
| |||
Form 4
| +5.37% | 175.65K |
$14.45 | $2,538,185.85 | 3.45M |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prometheus Biosciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.31M |
$19.00 |
—
| 3.31M |
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOSANTE PHARMACEUTICALS INC (ANIP) Snapshot price: $60.51
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -89.56% | -1.79M |
$4.27 | -$8,348,265.00 | 209.1K |
Dec 2 - Dec 3
| |||
Form 4
| +0.80% | 15.9K |
$9.87 | $156,856.68 | 2M |
Oct 8
| |||
Form 4
| +1.02% | 20K |
$10.00 | $200,084.00 | 1.99M |
Oct 6 - Oct 7
| |||
Form 4
| +1.65% | 32K |
$9.82 | $314,196.65 | 1.97M |
Oct 4 - Oct 5
| |||
Form 4
| +1.66% | 31.5K |
$9.39 | $295,830.00 | 1.93M |
Sep 30 - Oct 1
| |||
Form 4
| +1.30% | 24.5K |
$7.69 | $188,287.40 | 1.9M |
Sep 14
| |||
Form 4
| +1.40% | 25.9K |
$7.17 | $185,653.79 | 1.88M |
Sep 13
| |||
Form 4
| +0.25% | 4.7K |
$6.85 | $32,195.00 | 1.85M |
Sep 9
| |||
Form 4
| +1.04% | 19K |
$6.84 | $129,936.70 | 1.85M |
Aug 30 - Aug 31
| |||
Form 4
| +2.92% | 51.9K |
$5.83 | $302,466.24 | 1.83M |
Aug 18 - Aug 19
| |||
Form 4
|
—
|
0
|
$5.30 | -$80.00 | 7.25K |
Aug 16
| |||
Form 4
| +0.14% | 2.5K |
$4.75 | $11,875.00 | 1.77M |
Aug 12
| |||
Form 4
| +1.35% | 23.6K |
$4.72 | $111,333.00 | 1.77M |
Aug 11
| |||
Form 4
| +1.65% | 28.45K |
$5.67 | $161,456.56 | 1.75M |
Jul 19
| |||
Form 4
| +1.27% | 21.55K |
$5.91 | $127,434.18 | 1.72M |
Jul 15 - Jul 16
| |||
Form 4/A
| +61.90% | 650K |
$6.00 | $3,900,000.00 | 1.7M |
May 14
| |||
Form 4
| +61.90% | 650K |
$6.00 | $3,900,000.00 | 1.7M |
May 11
| |||
Form 4
| -7.68% | -87.40K |
$6.44 | -$562,576.32 | 1.05M |
Feb 3
| |||
Form 4
| -18.31% | -255.00K |
$5.67 | -$1,446,550.00 | 1.14M |
Jan 21 - Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||